Sanofi Receives Indian Marketing Approval for Dupixent to treat Adults with Moderate-to-Severe Atopic Dermatitis

Sanofi Healthcare India Pvt. Ltd. announced that Dupixent (dupilumab), the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies...

UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV

The vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths each year, has been approved by the UK's health regulator, according to GSK....

Hans Foundation & AIIMS to Establish Advanced Unit for Early Childhood Development & Neurorehabilitation Centre

The Hans Foundation and the Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Paediatrics, AIIMS signed a collaboration agreement to carry out the project, Holding Hand ...

India's Domestic Pharmaceutical Sector is Expected to Reach $57 billion by FY25

According to CareEdge Ratings, the domestic pharmaceutical business is predicted to reach $57 billion by FY25, with operating margins increasing by 100-150 basis points (bps). From FY18 to FY23, the Indian pharmaceutical business grew at a 6-8%...

India's pharma Industry set to Capitalize on Major Opportunities in the US Generics Market

Major players with exposure to the US market, including Zydus Lifesciences, Torrent Pharma, Aurobindo Pharma, and Ajanta Pharma, are expected to be the primary beneficiaries of this upcycle, the report said...

Central Govt launches DNK Portal for MSMEs Exporting Pharma Goods to Various Countries

To ease the process of pharma exports and facilitate the transmission of pharma exporting goods, the Union Ministry of Communications has launched the Dak Ghar Niryat Kendra (DNK) portal for commercial customers or MSMEs to export goods seamlessly...

Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation

The Karnataka government has offered a boost to health and lifescience firms, with an emphasis on infrastructure and innovation. With a grant of Rs. 300 crore and an allocation of Rs. 14,950,496 crore for healthcare, the state has asked...

Alkem Labs Enters into Ophthalmology with Launch of Eye Care Products

Alkem Labs has announced its entry into the field of ophthalmology with the release of a comprehensive portfolio of low-cost, high-quality eye care products. This strategic expansion demonstrates Alkem's dedication to innovation and meeting....

Asieris Pharma Completes Patient Enrollment in Hexvix's Phase III Bridging trial for the Diagnosis of Bladder Cancer

Asieris Pharmaceuticals, a global biopharmaceutical company specialising in the discovery, development, and commercialization of innovative drugs for the treatment of genitourinary tumours and other related diseases, announced the completion...

India is emerging as a Preferred Destination for CRAMS due to a combination of factors, say Experts

Indian pharmaceutical & nutraceutical companies are increasingly recognizing the advantages of outsourcing various aspects of their operations, intensifying their focus on this strategic approach to offer a competitive cost structure, which makes ...

© 2025 India Pharma Outlook. All Rights Reserved.